![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Pronóstico del mercado europeo de fraccionamiento de plasma hasta 2028: impacto de COVID-19 y análisis regional por producto (inmunoglobulina, albúmina, concentrados de factor de coagulación, inhibidores de proteasa y otros productos plasmáticos), aplicación (neurología, inmunología, hematología, cuidados intensivos, neumología y otros) Aplicaciones) y usuario final (hospitales y clínicas, laboratorios de investigación clínica e institutos académicos)
Introducción al mercado
El mercado europeo de fraccionamiento de plasma incluye los mercados consolidados de Alemania, Francia, Reino Unido, España, Italia y resto de Europa. Europa ocupa una posición importante en el mercado mundial de fraccionamiento de plasma y se estima que registrará una sólida tasa de crecimiento durante el período previsto. Se espera que el crecimiento del mercado en la región debido al envejecimiento de la población, el aumento del uso de inmunoglobulinas para tratar diversas enfermedades crónicas, el aumento de la prevalencia de trastornos inmunológicos y hemorrágicos y el aumento de las terapias con plasma para el manejo de enfermedades impulsen el crecimiento del mercado para la región de Europa durante el período de pronóstico.
En los países europeos, la práctica médica de diversas enfermedades crónicas, como trastornos neurológicos, trastornos hematológicos y enfermedades respiratorias, ha cambiado. Debido a la diversificación del personal médico y la decisión de centrarse en el tratamiento de los enfermos críticos, el aumento de la COVID-19 ha afectado la detección y el tratamiento de enfermedades. Debido a la pandemia actual, muchas organizaciones de investigación se están centrando más en los estudios de COVID-19 y están trabajando arduamente para comprender mejor el virus. Algunas de las agencias federales de la región han tomado la iniciativa de adoptar la terapia con plasma para tratar a los pacientes con COVID-19. Por ejemplo, la Agencia Nacional para la Seguridad de Medicamentos y Productos Sanitarios de Francia (ANSM) anunció que la terapia con plasma inmunológico se utilizaría en el tratamiento de pacientes críticamente enfermos. Asimismo, la Comisión Europea recomendó el uso de emergencia de la terapia con plasma de convalecientes para tratar a pacientes críticos. Por lo tanto, el uso de terapias con plasma en el manejo de COVID-19 ha impactado positivamente en el mercado hasta cierto punto. Sin embargo, debido a la COVID-19, la práctica médica general de los trastornos neurológicos, los trastornos hematológicos y los trastornos idiosincrásicos ha cambiado, y la mayoría de las compañías farmacéuticas y biofarmacéuticas están haciendo hincapié en el desarrollo de nuevas terapias de tratamiento para la COVID-19, lo que está afectando negativamente a la salud. el crecimiento del mercado.
< p>Visión general y dinámica del mercadoEl mercado de fraccionamiento de plasma en Europa Se espera que crezca de US$ 6.824,67 millones en 2021 a US$ 10.402,95 millones en 2028; se estima que crecerá a una tasa compuesta anual del 6,2% de 2021 a 2028. Aumento de la población geriátrica, aumento del uso de inmunoglobulinas en diversas áreas terapéuticas como neurología, hematología, trastornos genéticos raros y trastornos autoinmunes junto con una creciente demanda de terapias derivadas de plasma para su tratamiento. Se espera que todos los tipos de enfermedades impulsen el mercado de fraccionamiento de plasma en el resto de Europa. Además, varias empresas en Europa están invirtiendo más en actividades de investigación y desarrollo para desarrollar y lanzar enfoques novedosos en terapias con plasma para el tratamiento de enfermedades.
Segmentos de mercado clave
El mercado europeo de fraccionamiento de plasma está segmentado por producto, aplicación, usuario final y país. El mercado europeo de fraccionamiento de plasma, según el producto, se ha segmentado en inmunoglobulinas, albúmina, concentrados de factores de coagulación, inhibidores de proteasa y otros. Es probable que el segmento de inmunoglobulinas tenga la mayor participación del mercado en 2021. El mercado europeo de fraccionamiento de plasma, según la aplicación, se segmenta en neurología, inmunología, hematología, cuidados intensivos, neumología y otros. En 2021, es probable que el segmento de Neurología tenga la mayor cuota de mercado. El mercado europeo de fraccionamiento de plasma, basado en el usuario final, está segmentado en hospitales y clínicas, laboratorios de investigación clínica e institutos académicos. En 2021, es probable que el segmento de hospitales y clínicas tenga la mayor participación del mercado. Según el país, el mercado europeo de fraccionamiento de plasma está segmentado en Francia, Alemania, Italia, España, Reino Unido y el resto de Europa. El resto de Europa tuvo la mayor cuota de mercado en 2021.
Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de fraccionamiento de plasma en Europa son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos de los gobiernos nacionales y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Bharat Serums and Vaccines Limited (BSV); Laboratorio de Productos Bio Ltd.; Biotest AG; CSL limitada; Grifols, SA; Kedrion SpA; Octapharma AG; Sanquín; y SK Plasma.
Informe de razones para comprar
- Comprender el panorama del mercado europeo de fraccionamiento de plasma e identificar los segmentos del mercado que tienen más probabilidades de garantizar una fuerte retorno.
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado europeo de fraccionamiento de plasma.
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado europeo de fraccionamiento de plasma identificando segmentos de mercado con las ventas probables más prometedoras.
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo de Rendimiento del mercado de varios segmentos del mercado europeo de fraccionamiento de plasma.
- Obtener una previsión de ingresos de mercado para varios segmentos entre 2021 y 2028 en la región de Europa.
Europa Mercado de fraccionamiento de plasma Segmentación
Mercado europeo de fraccionamiento de plasma - Por producto
- Inmunoglobulina
- Inmunoglobulina intravenosa (IVIG)
- Inmunoglobulina subcutánea (SCIG)
- Albúmina
- Concentrados de factor de coagulación
- Inhibidores de proteasa
- Otros
Mercado europeo de fraccionamiento de plasma - Por Aplicación
- Neurología
- Inmunología
- Hematología
- Cuidados críticos
- Neumología
- Otros
Mercado europeo de fraccionamiento de plasma: por usuario final
- Hospitales y clínicas
- Laboratorios de investigación clínica
- Institutos académicos
Mercado europeo de fraccionamiento de plasma: por país
- Francia
- Alemania
- Italia
- España
- Reino Unido
- Resto de Europa
Mercado europeo de fraccionamiento de plasma: perfiles de empresas
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limitada
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- Sanquin
- SK Plasma
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Plasma Fractionation Market – By Product
1.3.2 Europe Plasma Fractionation Market – By Application
1.3.3 Europe Plasma Fractionation Market – By End User
1.3.4 Europe Plasma Fractionation Market – By Country
2. Europe Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy Being Widely Used
5.1.2 Market is Developing Due to Active Participation of the Key Players
5.2 Market Restraints
5.2.1 Alternate Non-Plasma Substitutes Available
5.3 Future Trends
5.3.1 Novel Diseases Getting Treated By Using Plasma Therapy
5.4 Impact Analysis
6. Plasma Fractionation Market – Europe Analysis
6.1 Europe Plasma Fractionation Market Revenue Forecast and Analysis
7. Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1 France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1 UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3.1 Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3.1 Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanquin
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bharat Serums and Vaccines Limited (BSV)
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SK Plasma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11. UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic developments done by Companies
Table 27. Glossary of Terms, Plasma Fractionation Market
LIST OF FIGURES
Figure 1. Europe Plasma Fractionation Market Segmentation
Figure 2. Europe Plasma Fractionation Market Segmentation, By Country
Figure 3. Europe Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market
Figure 8. Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Impact of COVID-19 Pandemic in European Country Markets
Figure 37. Growth Strategies Followed by Major Market Players (%)- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution